Nilutamide
Top View
- Perioperative Medication Management - Adult/Pediatric - Inpatient/Ambulatory Clinical Practice Guideline
- Brand Generic Guide
- Decision Trees to Characterise the Roles of Permeability and Solubility on the Prediction of Oral Absorption
- Clinical Rationale NILANDRON (Nilutamide)
- Design and Synthesis of Novel Bicalutamide and Enzalutamide Derivaaves As Anaproliferaave Agents for the Treatment of Prostat
- FEP 5 Tier Rx Drug Formulary (607) Standard Option
- (Nilutamide) Tablets 50 Mg Nonsteroidal Antiandrogen
- In the Treatment of Patients with Prostate Cancer
- NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2014
- Enzalutamide Drug Monograph
- Clinical Policy: Enzalutamide (Xtandi) Reference Number: CP.CPA.203 Effective Date: 11.16.16 Last Review Date: 02.20 Line of Business: Commercial Revision Log
- Xtandi, INN-Enzalutamide
- Federal Register/Vol. 77, No. 16/Wednesday, January 25, 2012
- DRUG NAME: Flutamide
- Oncology Agents, Prostate Cancer
- Is There a Role for Antiandrogen Monotherapy in Patients with Metastatic Prostate Cancer?
- Dunning R3327)
- Zytiga, INN-Abiraterone Acetate